Controlling gene expression in yeast by inducible site-specific recombination.
An intron module was developed for Saccharomyces cerevisiae that imparts conditional gene regulation. The kanMX marker, flanked by loxP sites for the Cre recombinase, was embedded within the ACT1 intron and the resulting module was targeted to specific genes by PCR-mediated gene disruption. Initially, recipient genes were inactivated because the loxP-kanMX-loxP cassette prevented formation of mature transcripts. However, expression was restored by Cre-mediated site-specific recombination, which excised the loxP-kanMX-loxP cassette to generate a functional intron that contained a single loxP site. Cre recombinase activity was controlled at the transcriptional level by a GAL1::CRE expression vector or at the enzymatic level by fusing the protein to the hormone-dependent regulatory domain of the estrogen receptor. Negative selection against leaky pre-excision events was achieved by growing cells in modified minimal media that contained geneticin (G418). Advantages of this gene regulation technique, which we term the conditional knock-out approach, are that (i) modified genes are completely inactivated prior to induction, (ii) modified genes are induced rapidly to expression levels that compare to their unmodified counterparts, and (iii) it is easy to use and generally applicable.
Cheng
T H
TH
Department of Pharmacology, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, Piscataway, NJ 08854, USA.
Chang
C R
CR
Joy
P
P
Yablok
S
S
Gartenberg
M R
MR
D001287:Attachment Sites, Microbiological / Q000235:genetics; D003470:Culture Media; D004271:DNA, Fungal / Q000235:genetics / Q000378:metabolism; D004274:DNA, Recombinant / Q000235:genetics / Q000378:metabolism; D004790:Enzyme Induction; D005656:Fungal Proteins / Q000235:genetics / Q000502:physiology; D015966:Gene Expression Regulation, Fungal; D020868:Gene Silencing; D005800:Genes, Fungal / Q000235:genetics; D005839:Gentamicins / Q000494:pharmacology; D006801:Humans; D019426:Integrases / Q000096:biosynthesis / Q000235:genetics / Q000378:metabolism*; D007438:Introns / Q000235:genetics; D007700:Kinetics; D016297:Mutagenesis, Site-Directed / Q000235:genetics*; D012331:RNA, Fungal / Q000235:genetics / Q000378:metabolism; D011960:Receptors, Estrogen / Q000235:genetics; D011995:Recombination, Genetic / Q000235:genetics*; D015203:Reproducibility of Results; D012441:Saccharomyces cerevisiae / Q000187:drug effects / Q000235:genetics* / Q000254:growth & development; D017384:Sequence Deletion / Q000235:genetics*; D012689:Sequence Homology, Nucleic Acid; D038281:Silent Information Regulator Proteins, Saccharomyces cerevisiae; D013698:Templates, Genetic; D015534:Trans-Activators / Q000235:genetics / Q000502:physiology; D014764:Viral Proteins
D003470:Culture Media; D004271:DNA, Fungal; D004274:DNA, Recombinant; D005656:Fungal Proteins; D005839:Gentamicins; D012331:RNA, Fungal; D011960:Receptors, Estrogen; C084122:SIR3 protein, S cerevisiae; D038281:Silent Information Regulator Proteins, Saccharomyces cerevisiae; D015534:Trans-Activators; D014764:Viral Proteins; C010680:antibiotic G 418; C045073:Cre recombinase; D019426:Integrases